Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · IEX Real-Time Price · USD
0.970
-0.070 (-6.73%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $33.71 million as of April 26, 2024. Its market cap has increased by 28.68% in one year.
Market Cap
33.71M
Enterprise Value
24.81M
1-Year Change
28.68%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has decreased from $66.49M to $33.71M, a decrease of -49.29%. That is a compound annual growth rate of -21.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 36.10M | -2.96% |
Apr 23, 2024 | 37.20M | -7.00% |
Apr 22, 2024 | 40.00M | 7.53% |
Apr 19, 2024 | 37.20M | -1.85% |
Apr 18, 2024 | 37.90M | -5.49% |
Apr 17, 2024 | 40.10M | 3.08% |
Apr 16, 2024 | 38.90M | -1.77% |
Apr 15, 2024 | 39.60M | -6.60% |
Apr 12, 2024 | 42.40M | -2.30% |
Apr 11, 2024 | 43.40M | -3.98% |
Apr 10, 2024 | 45.20M | -1.53% |
Apr 9, 2024 | 45.90M | -4.57% |
Apr 8, 2024 | 48.10M | -2.63% |
Apr 5, 2024 | 49.40M | -2.56% |
Apr 4, 2024 | 50.70M | 6.51% |
Apr 3, 2024 | 47.60M | -0.83% |
Apr 2, 2024 | 48.00M | -2.04% |
Apr 1, 2024 | 49.00M | 2.08% |
Mar 28, 2024 | 48.00M | -5.33% |
Mar 27, 2024 | 50.70M | 0.60% |
Mar 26, 2024 | 50.40M | -4.55% |
Mar 25, 2024 | 52.80M | 3.33% |
Mar 22, 2024 | 51.10M | 10.61% |
Mar 21, 2024 | 46.20M | -6.48% |
Mar 20, 2024 | 49.40M | 2.28% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Bright Green | 34.99M |
Protara Therapeutics | 34.87M |
VYNE Therapeutics | 34.82M |
Precision Optics Corporation | 34.41M |
electroCore | 33.91M |
Evogene | 33.32M |
Viracta Therapeutics | 33.26M |
Fortress Biotech | 33.08M |